Source: International Congress 2015 – IPF pathogenesis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Shinichiro Ohshimo (Hiroshima, Japan), Shinichiro Ohshimo, Chihiro Yamaoka, Yasush Horimasu, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori, Nobuyuki Hirohashi, Koichi Tanigawa, Francesco Bonella, Josune Guzman, Ulrich Costabel, Nobuoki Kohno. Comparative analysis of multiple gene polymorphisms for acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir J 2015; 46: Suppl. 59, 3510

Member's Comments

No comment yet.

Related content which might interest you: Cytofluorimetric BAL cells characterization in IPF and in other ILD Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Transcriptome analysis in endobronchial epithelial lining fluid compared to bronchoalveolar lavage in idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Analysis of inflammatory networks in interstitial lung disease in patients with rheumatoid arthritis Source: International Congress 2016 – Connective tissue disorders Year: 2016 Impact of lymphocyte differential count in BALF on the mortality of patients with acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 The effect of MUC5B promoter polymorphism on susceptibility to idiopathic interstitial pneumonias and cell profiles in bronchoalveolar Lavage fluid Source: International Congress 2015 – IPF pathogenesis Year: 2015 Familial and sporadic IPF: A proteomic comparison Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Galactomannans in bronchoalveolar lavage of patients with Idiopathic Pulmonary Fibrosis (IPF): a possible marker of disease progression. Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Sampling the lung fluids: peripheral biomarkers Source: Annual Congress 2007 - Pulmonary biomarkers in COPD Year: 2007 Correlation between imaging fibrosis severity and bronchoalveolar lavage pattern in interstitial lung disease Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Main features of cytokine profile in serum and bronchoalveolar lavage fluid in patients with recurrent sarcoidosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Clinical and immunological parameters in patients with newly diagnosed sarcoidosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Effect of low level laser therapy in a model of pulmonary idiopathic fibrosis Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Screening potential biomarkers for idiopathic pulmonary fibrosis in bronchoalveolar lavage fluid Source: International Congress 2014 – ILDs 1 Year: 2014 Increased apoptosis of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF). Potential mechanisms and practical considerations Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Cytokine profile in bronchoalveolar lavage fluid of fibrotic idiopathic intersticial pneumonias compared to fibrotic intersticial pneumonias in connective tissue diseases Source: International Congress 2016 – Connective tissue disorders Year: 2016 The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases? Source: International Congress 2015 – New insights into IIPs Year: 2015